| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1994 | Volume 120 Issue 1 | Pages 56-64
Purpose: To provide information about available agents for chemical pleurodesis.
Data Sources: A MEDLINE search (1966 to October 1992) was conducted using the terms malignant pleural effusion and pleurodesis.
Study Selection: All articles containing references to patients with recurrent, symptomatic, malignant pleural effusions treated with chemical pleurodesis were selected and reviewed for pleurodesis regimen, number of patients treated, success rate (complete response), and adverse effects. The agents studied included doxycycline, minocycline, tetracycline, bleomycin, cisplatin, doxorubicin, etoposide, fluorouracil, interferon-ß, mitomycin-c, Corynebacterium parvum, methylprednisolone, and talc.
Data Extraction: Independent extraction by three observers.
Results: Studies including a total of 1168 patients with malignant pleural effusions were reviewed for efficacy of the pleurodesis agent and studies including 1140 patients were reviewed for toxicity. Chemical pleurodesis produced a complete response in 752 (64%) of 1168 patients. The success rate of the pleurodesis agents varied from 0% with etoposide to 93% with talc. Corynebacterium parvum, the tetracyclines, and bleomycin had success rates of 76%, 67%, and 54%, respectively. The most commonly reported adverse effects were pain (265 of 1140, 23%) and fever (220 of 1140, 19%).
Conclusions: Doxycycline and minocycline, with success rates of 72% and 86%, respectively, appear to be effective tetracycline-replacement agents in the few patients studied. Talc appears to be the most effective and least expensive agent; however, insufflation has the disadvantages of the expense of thoracoscopy and the usual need for general anesthesia. Bleomycin appears to be less effective than talc and the tetracyclines and is substantially more expensive.
Author and Article Information
From the College of Medicine, Medical University of South Carolina, Charleston, South Carolina.
REVIEW
Chemical Pleurodesis for Malignant Pleural Effusions
![]()
Requests For Reprints: Leigh M. Vaughan, PharmD, College of Pharmacy, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425-0810.
This article has been cited by other articles:
![]() |
B. Caglayan, E. Torun, D. Turan, A. Fidan, C. Gemici, G. Sarac, B. Salepci, and N. Kiral Efficacy of Iodopovidone Pleurodesis and Comparison of Small-Bore Catheter Versus Large-Bore Chest Tube Ann. Surg. Oncol., September 1, 2008; 15(9): 2594 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Najmunnisa, K. A. Mohammed, S. Brown, Y. Su, P. S. Sriram, B. Moudgil, R. Loddenkemper, and V. B. Antony Talc mediates angiostasis in malignant pleural effusions via endostatin induction Eur. Respir. J., April 1, 2007; 29(4): 761 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kuzniar, M. G. Blum, K. Kasibowska-Kuzniar, and G. M. Mutlu Predictors of Acute Lung Injury and Severe Hypoxemia in Patients Undergoing Operative Talc Pleurodesis Ann. Thorac. Surg., December 1, 2006; 82(6): 1976 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marchi, F. S. Vargas, M. M. Acencio, L. Antonangelo, E. H. Genofre, and L. R. Teixeira Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis Eur. Respir. J., November 1, 2006; 28(5): 929 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Montes, J. Garcia-Valero, and J. Ferrer Evidence of Innervation in Talc-Induced Pleural Adhesions. Chest, September 1, 2006; 130(3): 702 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rodriguez-Panadero, J. P. Janssen, and P. Astoul Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur. Respir. J., August 1, 2006; 28(2): 409 - 422. [Full Text] [PDF] |
||||
![]() |
C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Psathakis, E. Calderon-Osuna, B. Romero-Romero, J. Martin-Juan, A. Romero-Falcon, and F. Rodriguez-Panadero The neutrophilic and fibrinolytic response to talc can predict the outcome of pleurodesis. Eur. Respir. J., April 1, 2006; 27(4): 817 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Avila, A. J. Dwyer, A. Rabel, R. M. DeCastro, and J. Moss CT of Pleural Abnormalities in Lymphangioleiomyomatosis and Comparison of Pleural Findings After Different Types of Pleurodesis. Am. J. Roentgenol., April 1, 2006; 186(4): 1007 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tremblay and G. Michaud Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest, February 1, 2006; 129(2): 362 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits Chest, November 1, 2005; 128(5): 3735 - 3742. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kolschmann, A. Ballin, and A. Gillissen Clinical Efficacy and Safety of Thoracoscopic Talc Pleurodesis in Malignant Pleural Effusions Chest, September 1, 2005; 128(3): 1431 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marchi, F. S. Vargas, L. R. Teixeira, M. M. P. Acencio, L. Antonangelo, and R. W. Light Intrapleural Low-Dose Silver Nitrate Elicits More Pleural Inflammation and Less Systemic Inflammation Than Low-Dose Talc Chest, September 1, 2005; 128(3): 1798 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Okereke, S. C. Murthy, J. M. Alster, E. H. Blackstone, and T. W. Rice Characterization and Importance of Air Leak After Lobectomy Ann. Thorac. Surg., April 1, 2005; 79(4): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Antony, N. Nasreen, K. A. Mohammed, P. S. Sriram, W. Frank, N. Schoenfeld, and R. Loddenkemper Talc Pleurodesis: Basic Fibroblast Growth Factor Mediates Pleural Fibrosis Chest, November 1, 2004; 126(5): 1522 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ren, D. S. Terman, G. Bohach, A. Silvers, C. Hansen, H. Colt, and S. A. Sahn Intrapleural Staphylococcal Superantigen Induces Resolution of Malignant Pleural Effusions and a Survival Benefit in Non-Small Cell Lung Cancer Chest, November 1, 2004; 126(5): 1529 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kishi, S. Homma, S. Sakamoto, M. Kawabata, E. Tsuboi, K. Nakata, and K. Yoshimura Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Eur. Respir. J., August 1, 2004; 24(2): 263 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marchi, F. S. Vargas, M. M. P. Acencio, L. Antonangelo, L. R. Teixeira, E. H. Genofre, and R. W. Light Talc and Silver Nitrate Induce Systemic Inflammatory Effects During the Acute Phase of Experimental Pleurodesis in Rabbits Chest, June 1, 2004; 125(6): 2268 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Chen, H.-H. Hsu, S.-W. Kuo, P.-R. Tsai, R. J. Chen, J.-M. Lee, and Y.-C. Lee Effects of Additional Minocycline Pleurodesis After Thoracoscopic Procedures for Primary Spontaneous Pneumothorax Chest, January 1, 2004; 125(1): 50 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. G. Lee, M. H. Baumann, N. A. Maskell, G. W. Waterer, T. E. Eaton, R. J. O. Davies, J. E. Heffner, and R. W. Light Pleurodesis Practice for Malignant Pleural Effusions in Five English-Speaking Countries: Survey of Pulmonologists Chest, December 1, 2003; 124(6): 2229 - 2238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Parker and E Neville Lung cancer * 8: Management of malignant mesothelioma Thorax, September 1, 2003; 58(9): 809 - 813. [Full Text] [PDF] |
||||
![]() |
S. Tang, W. H. Chui, A. W. C. Tang, F. K. Li, W. S. Chau, Y. W. Ho, T. M. Chan, and K. N. Lai Video-assisted thoracoscopic talc pleurodesis is effective for maintenance of peritoneal dialysis in acute hydrothorax complicating peritoneal dialysis Nephrol. Dial. Transplant., April 1, 2003; 18(4): 804 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. North, H.-J. Au, S. B. Halls, L. Tkachuk, and J. R. Mackey A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Intrapleural Instillation of Methylprednisolone Acetate in the Management of Malignant Pleural Effusion Chest, March 1, 2003; 123(3): 822 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123(1_suppl): 284S - 311S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fraticelli, A. Robaglia-Schlupp, H. Riera, S. Monjanel-Mouterde, P. Cau, and P. Astoul Distribution of Calibrated Talc After Intrapleural Administration: An Experimental Study in Rats Chest, November 1, 2002; 122(5): 1737 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Marom, J. J. Erasmus, J. E. Herndon II, C. Zhang, and H. P. McAdams Usefulness of Imaging-Guided Catheter Drainage and Talc Sclerotherapy in Patients with Metastatic Gynecologic Malignancies and Symptomatic Pleural Effusions Am. J. Roentgenol., July 1, 2002; 179(1): 105 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn Management of malignant pleural effusions Eur. Respir. J., August 1, 2001; 18(2): 402 - 419. [Full Text] [PDF] |
||||
![]() |
F. S. Vargas, L. R. Teixeira, L. Antonangelo, M. A. C. Vaz, A. O. Carmo, E. Marchi, and R. W. Light Experimental Pleurodesis in Rabbits Induced by Silver Nitrate or Talc : 1-Year Follow-up Chest, May 1, 2001; 119(5): 1516 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
British Thoracic Society Standards of Care Committ Statement on malignant mesothelioma in the United Kingdom Thorax, April 1, 2001; 56(4): 250 - 265. [Full Text] |
||||
![]() |
Y. C. GARY LEE, L. R. TEIXEIRA, C. J. DEVIN, M. A. C. VAZ, F. S. VARGAS, P. J. THOMPSON, K. B. LANE, and R. W. LIGHT Transforming Growth Factor-{beta}2 Induces Pleurodesis Significantly Faster than Talc Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 640 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Sahn Talc Should Be Used for Pleurodesis Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2023 - 2024. [Full Text] |
||||
![]() |
S. Sahn REBUTTAL FROM DR. SAHN Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2026 - 2026. [Full Text] |
||||
![]() |
G ANTUNES and E NEVILLE Management of malignant pleural effusions Thorax, December 1, 2000; 55(12): 981 - 983. [Full Text] |
||||
![]() |
Y C G Lee, K B Lane, R E Parker, D S Ayo, J T Rogers, R W Diters, P J Thompson, and R W Light Transforming growth factor beta 2 (TGFbeta 2) produces effective pleurodesis in sheep with no systemic complications Thorax, December 1, 2000; 55(12): 1058 - 1062. [Abstract] [Full Text] |
||||
![]() |
Management of Malignant Pleural Effusions Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001. [Full Text] |
||||
![]() |
D. Bouros, M. Froudarakis, and N. M. Siafakas Pleurodesis : Everything Flows Chest, September 1, 2000; 118(3): 577 - 579. [Full Text] [PDF] |
||||
![]() |
F. S. Vargas, L. R. Teixeira, M. A.C. Vaz, A. O. Carmo, E. Marchi, P. M. Cury, and R. W. Light Silver Nitrate Is Superior to Talc Slurry in Producing Pleurodesis in Rabbits Chest, September 1, 2000; 118(3): 808 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. LIGHT, D.-S. CHENG, Y. C. G. LEE, J. ROGERS, J. DAVIDSON, and K. B. LANE A Single Intrapleural Injection of Transforming Growth Factor-beta 2 Produces an Excellent Pleurodesis in Rabbits Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 98 - 104. [Abstract] [Full Text] |
||||
![]() |
T. Kinoshita, S. Miyoshi, M. Katoh, T. Yoshimasu, M. Juri, S. Maebeya, and Y. Naito Intrapleural Administration of a Large Amount of Diluted Fibrin Glue for Intractable Pneumothorax Chest, March 1, 2000; 117(3): 790 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Heffner, P. J. Nietert, and C. Barbieri Pleural Fluid pH as a Predictor of Pleurodesis Failure* : Analysis of Primary Data Chest, January 1, 2000; 117(1): 87 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Macaulay, K. J. O'Byrne, M. P. Saunders, J. P. Braybrooke, L. Long, F. Gleeson, C. S. Mason, A. L. Harris, P. Brown, and D. C. Talbot Phase I Study of Intrapleural Batimastat (BB-94), a Matrix Metalloproteinase Inhibitor, in the Treatment of Malignant Pleural Effusions Clin. Cancer Res., March 1, 1999; 5(3): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Werebe, R. Pazetti, J. R. Milanez de Campos, P. P. Fernandez, V. L. Capelozzi, F. B. Jatene, and F. S. Vargas Systemic Distribution of Talc After Intrapleural Administration in Rats Chest, January 1, 1999; 115(1): 190 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis Radiology, January 1, 1999; 210(1): 277 - 281. [Abstract] [Full Text] |
||||
![]() |
G. Massard, P. Thomas, and J.-M. Wihlm Minimally invasive management for first and recurrent pneumothorax Ann. Thorac. Surg., August 1, 1998; 66(2): 592 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Cohen, W. W. Shely, S. E. Thompson, J. A. Hagen, C. C. Marboe, T. R. DeMeester, and V. A. Starnes Talc Pleurodesis: Talc Slurry Versus Thoracoscopic Talc Insufflation in a Porcine Model Ann. Thorac. Surg., October 1, 1996; 62(4): 1000 - 1002. [Abstract] [Full Text] |
||||